All News #Library
Boehringer Ingelheim Pharma’s Jascayd Receives Approval in US
19 Dec 2025 //
FDA
Boehringer Ingelheim’s Jascayd Receives Approval In US
07 Oct 2025 //
FDA
Boehringer’s Hernexeos Receives Approval in US
08 Aug 2025 //
FDA
Boehringer `s Biologics Spevigo Receives Suppl Approval in US
28 May 2025 //
FDA
Boehringer`s Biologics Cyltezo Receives Suppl Approval in US
20 May 2025 //
FDA
Boehringer`s Biologic Cyltezo (Adalimumab) Receives Approval in the U.S.
30 Jun 2023 //
FDA
Boehringer Ingelheim`s Spevigo (Spesolimab) Approved In Europe
08 Feb 2023 //
EMA
Boehringer`s Biologic Spevigo (Spesolimab) Receives Approval in the U.S.
01 Sep 2022 //
FDA
Boehringer`s Biologic Spevigo (Spesolimab) Receives Approval in the U.S.
01 Sep 2022 //
FDA
Boehringer`s Biologic Praxbind (Idarucizumab) Receives Approval in the U.S.
11 Feb 2022 //
FDA
Olodaterol - List of nationally authorised medicinal products in Europe
25 Oct 2018 //
EMA
Boehringer Ingelheim`s Cyltezo (adalimumab) Receives Approval In Europe
18 Nov 2017 //
EMA
Boehringer Ingelheim’s Cyltezo Adalimumab-Adbm Receives
25 Aug 2017 //
FDA

Market Place
Sourcing Support